Establishing risk groups of multidrug-resistant tuberculosis and planning its therapeutic approach

Abstract

Patients with a failure of the first and second course of chemotherapy have a high risk of multidrug resistance tuberculosis amoung 227 persons under study (with the rate over 80 %); patients with a tuberculosis relapse – with the rate – 52,3 %, patients with interrupted treatment according to clinical category I – 43,3 %